Clearstead Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Clearstead Advisors’s Portfolio BCAT Stock Details BCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Sell	83,423 -1,000	-1%	-$14.7K	0.01%	469
2025 Q4	$1.2M	Hold	84,423	–	–	0.02%	426
2025 Q3	$1.25M	Hold	84,423	–	–	0.02%	402
2025 Q2	$1.28M	Buy	84,423 +1,003	+1%	+$14.6K	0.02%	391
2025 Q1	$1.2M	Buy	83,420 +960	+1%	+$14.7K	0.02%	377
2024 Q4	$1.25M	Buy	82,460 +1,499	+2%	+$24.1K	0.02%	368
2024 Q3	$1.33M	Sell	80,961 -6,688	-8%	-$110K	0.02%	363
2024 Q2	$1.44M	Buy	+87,649	New	+$1.41M	0.02%	326

Other funds holding BCAT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Clearstead Advisors's BCAT Position: Q1 2026 in Review

Clearstead Advisors reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 1.2% in Q1 2026, selling an estimated $14.7K and leaving 83,423 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #469.

Clearstead Advisors first reported a position in BCAT in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.44M in Q2 2024. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

Clearstead Advisors held 83,423 shares of BlackRock Capital Allocation Term Trust worth $1.18M as of Q1 2026.
Clearstead Advisors sold 1,000 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $14.7K.
BlackRock Capital Allocation Term Trust made up 0.01% of Clearstead Advisors's portfolio in Q1 2026, its #469 holding.
Clearstead Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2024 and has held it in 8 quarters since.
Clearstead Advisors's BlackRock Capital Allocation Term Trust position peaked at $1.44M in Q2 2024.
100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.